An integrative structural biology approach to the study of T cell signaling

研究 T 细胞信号传导的综合结构生物学方法

基本信息

  • 批准号:
    10242813
  • 负责人:
  • 金额:
    $ 42.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-01 至 2023-08-31
  • 项目状态:
    已结题

项目摘要

Summary I propose to develop and apply innovative hybrid structural biology tools to investigate the molecular mechanism of signaling through the T cell receptor (TCR) complex. This is a fundamental adaptive immunity pathway through which cytotoxic CD8+ T cells can detect the presence of viruses and developing tumors in the body. Immune function is achieved through the continuous surveillance of antigen-presenting cells for short peptides displayed within the molecules of the Major Histocompatibility Complex (MHC) on the cell surface. Key to the initiation of signaling, is a multi-subunit membrane protein assembly consisting of a clonotypic TCR heterodimer that recognizes the peptide-MHC, together with the invariant CD3 co-receptor hexamer that relays an activation signal from the cell surface intracellularly, through the plasma membrane. Besides the fundamental basic science merit, characterizing this process at atomic detail has important clinical implications, as is suggested by the large number of immunodeficiencies resulting from dysregulation of the signaling components and their interactions. Despite a large number of functional and structural studies, elucidating the 3D structure of the signaling complex as a whole remains extremely challenging by conventional methods, due to its size and dynamic complexity. As a result, the interactions between the TCR and CD3 subunits and the crucial conformational changes needed for signaling remain incompletely characterized. With these bottlenecks in mind, I have developed a new methodology combining datasets from complementary approaches, such as NMR, SANS and cryoEM, together with computational modeling using the program Rosetta to solve the structures of such challenging complexes. Here, I propose to apply this powerful integrative approach to elucidate the T cell receptor complex structure, and to study its dynamic transitions between inactive and active conformations. My immediate goal is to determine the molecular basis of TCR/CD3 interactions and to characterize the crucial structural changes in receptor complex arrangement upon antigen recognition. As a long-term goal, I plan to use a structure-guided approach to engineer novel T cell receptors with custom specificities and signaling properties, to be used in emerging immunotherapy applications.
总结 我建议开发和应用创新的混合结构生物学工具来研究 通过T细胞受体(TCR)复合物进行信号传导的分子机制。这是一 细胞毒性CD 8 + T细胞可以通过基本的适应性免疫途径检测到 病毒的存在和体内肿瘤的发展。免疫功能是通过 持续监测抗原呈递细胞内展示的短肽, 主要组织相容性复合物(MHC)分子在细胞表面。入门钥匙 是一种多亚基膜蛋白组装体,由克隆型TCR 识别肽-MHC的异源二聚体,以及不变的CD 3共受体 一种六聚体,通过血浆在细胞内传递来自细胞表面的激活信号 膜的除了基本的基础科学价值,在原子水平上表征这一过程, 细节具有重要的临床意义,正如大量的 由信号传导组分及其代谢产物的失调引起的免疫缺陷 交互. 尽管进行了大量的功能和结构研究,但阐明了 信号复合体作为一个整体仍然是非常具有挑战性的传统方法,由于 它的大小和动态复杂性。因此,TCR和CD 3亚基之间的相互作用 并且信号传导所需的关键构象变化仍然没有完全表征。 考虑到这些瓶颈,我开发了一种新的方法, 互补的方法,如NMR,SANS和cryoEM,以及计算 使用Rosetta程序进行建模,以解决此类具有挑战性的复合物的结构。 在这里,我建议应用这种强大的整合方法来阐明T细胞受体 复杂的结构,并研究其动态转换之间的非活性和活性 构象我的近期目标是确定TCR/CD 3相互作用的分子基础 并表征抗原上受体复合物排列的关键结构变化 识别.作为一个长期目标,我计划使用结构引导的方法来设计新颖的T 具有定制特异性和信号传导特性的细胞受体,用于新兴的 免疫疗法的应用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling.
  • DOI:
    10.3389/fimmu.2018.01657
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
    Natarajan K;Jiang J;May NA;Mage MG;Boyd LF;McShan AC;Sgourakis NG;Bax A;Margulies DH
  • 通讯作者:
    Margulies DH
De novo design of a non-local β-sheet protein with high stability and accuracy.
  • DOI:
    10.1038/s41594-018-0141-6
  • 发表时间:
    2018-11
  • 期刊:
  • 影响因子:
    16.8
  • 作者:
    Marcos E;Chidyausiku TM;McShan AC;Evangelidis T;Nerli S;Carter L;Nivón LG;Davis A;Oberdorfer G;Tripsianes K;Sgourakis NG;Baker D
  • 通讯作者:
    Baker D
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nikolaos Sgourakis其他文献

Nikolaos Sgourakis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nikolaos Sgourakis', 18)}}的其他基金

Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
  • 批准号:
    10319575
  • 财政年份:
    2019
  • 资助金额:
    $ 42.98万
  • 项目类别:
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
  • 批准号:
    10531131
  • 财政年份:
    2019
  • 资助金额:
    $ 42.98万
  • 项目类别:
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
  • 批准号:
    10201060
  • 财政年份:
    2019
  • 资助金额:
    $ 42.98万
  • 项目类别:
Molecular mechanism of antigen editing by Class-I MHC Chaperones
I类MHC伴侣编辑抗原的分子机制
  • 批准号:
    10078937
  • 财政年份:
    2019
  • 资助金额:
    $ 42.98万
  • 项目类别:
An integrative structural biology approach to the study of T cell signaling -Equipment Supplement
研究 T 细胞信号转导的综合结构生物学方法 - 设备补充
  • 批准号:
    10260718
  • 财政年份:
    2017
  • 资助金额:
    $ 42.98万
  • 项目类别:
An integrative structural biology approach to the study of T cell signaling
研究 T 细胞信号传导的综合结构生物学方法
  • 批准号:
    10191789
  • 财政年份:
    2017
  • 资助金额:
    $ 42.98万
  • 项目类别:
A structural approach to the study of viral Immune interference mechanisms
研究病毒免疫干扰机制的结构方法
  • 批准号:
    9069732
  • 财政年份:
    2015
  • 资助金额:
    $ 42.98万
  • 项目类别:

相似海外基金

Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
  • 批准号:
    10751133
  • 财政年份:
    2023
  • 资助金额:
    $ 42.98万
  • 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
  • 批准号:
    10696138
  • 财政年份:
    2022
  • 资助金额:
    $ 42.98万
  • 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
  • 批准号:
    10663066
  • 财政年份:
    2022
  • 资助金额:
    $ 42.98万
  • 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
  • 批准号:
    10537159
  • 财政年份:
    2022
  • 资助金额:
    $ 42.98万
  • 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
  • 批准号:
    21K08723
  • 财政年份:
    2021
  • 资助金额:
    $ 42.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
  • 批准号:
    10156950
  • 财政年份:
    2021
  • 资助金额:
    $ 42.98万
  • 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
  • 批准号:
    10631854
  • 财政年份:
    2021
  • 资助金额:
    $ 42.98万
  • 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
  • 批准号:
    10153927
  • 财政年份:
    2021
  • 资助金额:
    $ 42.98万
  • 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
  • 批准号:
    10331830
  • 财政年份:
    2021
  • 资助金额:
    $ 42.98万
  • 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
  • 批准号:
    20K16294
  • 财政年份:
    2020
  • 资助金额:
    $ 42.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了